The University of Ottawa Fear of Cancer Recurrence International Colloquium
渥太华大学癌症复发恐惧国际研讨会
基本信息
- 批准号:325072
- 负责人:
- 金额:$ 0.73万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Miscellaneous Programs
- 财政年份:2015
- 资助国家:加拿大
- 起止时间:2015-02-01 至 2016-02-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
BACKGROUND: Fear of cancer recurrence (FCR) has been described as the sword of Damocles that hangs over patients for the rest of their lives. While there is a wide variability in patients' severity of their FCR, research has shown that severe FCR tends to
背景:对癌症复发的恐惧(FCR)被描述为悬在患者余生的达摩克利斯之剑。虽然患者的FCR严重程度存在很大的差异,但研究表明,严重的FCR倾向于
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lebel Sophie其他文献
Lebel Sophie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lebel Sophie', 18)}}的其他基金
Addressing fear of cancer recurrence in parents of pediatric cancer survivors: adapting the Fear Of Recurrence Therapy (FORT) for parents and establishing acceptability and feasibility.
解决儿科癌症幸存者父母对癌症复发的恐惧:为父母调整恐惧复发疗法(FORT)并建立可接受性和可行性。
- 批准号:
488491 - 财政年份:2023
- 资助金额:
$ 0.73万 - 项目类别:
Operating Grants
Living in limbo: The Experience of and Relationship between Fear of Progression, Illness Uncertainty, Symptom Burden, and Death Anxiety in Patients with Advanced or Metastatic Lung Cancer Receiving Immunotherapy or Targeted Therapy
生活在不确定之中:接受免疫治疗或靶向治疗的晚期或转移性肺癌患者对病情进展的恐惧、疾病的不确定性、症状负担和死亡焦虑的经历和关系
- 批准号:
478587 - 财政年份:2023
- 资助金额:
$ 0.73万 - 项目类别:
Operating Grants
Addressing fear of cancer recurrence in parents of pediatric cancer survivors: adapting the Fear Of Recurrence Therapy (FORT) for parents and establishing acceptability and feasibility.
解决儿科癌症幸存者父母对癌症复发的恐惧:为父母调整恐惧复发疗法(FORT)并建立可接受性和可行性。
- 批准号:
484366 - 财政年份:2023
- 资助金额:
$ 0.73万 - 项目类别:
Operating Grants
It is time to address fear of cancer recurrence in the family caregiver: a feasibility and acceptability study of an online version of the Fear Of Recurrence Therapy (FORT) for family caregivers.
现在是时候解决家庭护理人员对癌症复发的恐惧了:针对家庭护理人员的恐惧复发疗法 (FORT) 在线版本的可行性和可接受性研究。
- 批准号:
477304 - 财政年份:2022
- 资助金额:
$ 0.73万 - 项目类别:
Operating Grants
The use of survivorship care plans as a transition tool from the cancer center to primary care: an implementation science perspective to inform best practice.
使用幸存者护理计划作为从癌症中心到初级护理的过渡工具:从实施科学角度为最佳实践提供信息。
- 批准号:
395517 - 财政年份:2018
- 资助金额:
$ 0.73万 - 项目类别:
Operating Grants
Cognitive-Existential Intervention to address fear of recurrence in women with cancer
认知存在干预解决癌症女性对复发的恐惧
- 批准号:
182781 - 财政年份:2009
- 资助金额:
$ 0.73万 - 项目类别:
Operating Grants
相似国自然基金
中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
- 批准号:81673007
- 批准年份:2016
- 资助金额:54.0 万元
- 项目类别:面上项目
相似海外基金
I-Corps: Translation potential of using machine learning to predict oxaliplatin chemotherapy benefit in early colon cancer
I-Corps:利用机器学习预测奥沙利铂化疗对早期结肠癌疗效的转化潜力
- 批准号:
2425300 - 财政年份:2024
- 资助金额:
$ 0.73万 - 项目类别:
Standard Grant
Investigate the feasibility of altering cancer drug sensitivity through modulation of AHR activity
研究通过调节 AHR 活性改变癌症药物敏感性的可行性
- 批准号:
24K10327 - 财政年份:2024
- 资助金额:
$ 0.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation on naphthylisoquinoline alkaloids as potential antiausterity chemotherapy for pancreatic cancer
萘基异喹啉生物碱作为胰腺癌潜在抗紧缩化疗的研究
- 批准号:
23K26797 - 财政年份:2024
- 资助金额:
$ 0.73万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Intelligent Breast Cancer DiagnOsis and MonItoring Therapeutic Response Training Network (CanDoIt)
智能乳腺癌诊断和监测治疗反应训练网络(CanDoIt)
- 批准号:
EP/Y03693X/1 - 财政年份:2024
- 资助金额:
$ 0.73万 - 项目类别:
Research Grant
SpyTCR-RBNP - Engineering a highly targeted and biocompatible drug delivery system for solid cancer treatment
SpyTCR-RBNP - 设计用于实体癌症治疗的高度针对性和生物相容性的药物输送系统
- 批准号:
10095606 - 财政年份:2024
- 资助金额:
$ 0.73万 - 项目类别:
Collaborative R&D
e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean project supported by PanCare and Harmonic consortia
电子医疗工具可促进儿童到成年癌症患者、幸存者及其家人的生活质量平等 - 这是由 PanCare 和 Harmonic 联盟支持的 PanEuropean 项目
- 批准号:
10098114 - 财政年份:2024
- 资助金额:
$ 0.73万 - 项目类别:
EU-Funded
Development of the initial prototype of a pill sensor to detect colonic polyps and early bowel cancer
开发用于检测结肠息肉和早期肠癌的药丸传感器的初始原型
- 批准号:
MR/Y503411/1 - 财政年份:2024
- 资助金额:
$ 0.73万 - 项目类别:
Research Grant
Novel chelators for Scandium-44 in PET imaging of prostate cancer
用于前列腺癌 PET 成像的新型 Scandium-44 螯合剂
- 批准号:
2904564 - 财政年份:2024
- 资助金额:
$ 0.73万 - 项目类别:
Studentship
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 0.73万 - 项目类别:
Proton radiation therapy combined with immunotherapy for enhancing antitumor immune responses in pancreatic cancer murine models.
质子放射治疗与免疫治疗相结合,增强胰腺癌小鼠模型的抗肿瘤免疫反应。
- 批准号:
24K10423 - 财政年份:2024
- 资助金额:
$ 0.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)